about
Development of Novel Vaccines against Enterovirus-71Recent Progress towards Novel EV71 Anti-Therapeutics and VaccinesRecent developments in antiviral agents against enterovirus 71 infectionIs a multivalent hand, foot, and mouth disease vaccine feasible?Structure of human enterovirus 71 in complex with a capsid-binding inhibitorThe Enterovirus 71 A-particle Forms a Gateway to Allow Genome Release: A CryoEM Study of Picornavirus UncoatingStructures of the Procapsid and Mature Virion of Enterovirus 71 Strain 1095Picornavirus uncoating intermediate captured in atomic detailA Strain-Specific Epitope of Enterovirus 71 Identified by Cryo-Electron Microscopy of the Complex with Fab from Neutralizing AntibodyCombined approaches to flexible fitting and assessment in virus capsids undergoing conformational changeHuman Enterovirus 71 Uncoating Captured at Atomic ResolutionNeutralizing antibodies can initiate genome release from human enterovirus 71More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesLimits of Structural Plasticity in a Picornavirus Capsid Revealed by a Massively Expanded Equine Rhinitis A Virus ParticleMolecular mechanism of SCARB2-mediated attachment and uncoating of EV71Immunological and biochemical characterization of coxsackie virus A16 viral particlesInhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl PhosphateA sialic acid binding site in a human picornavirusThe Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan SulfateStructural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal AntibodyEfficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in MiceStructural analysis of coxsackievirus A7 reveals conformational changes associated with uncoatingEffective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activityA novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection.Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine developmentCyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulatorIdentification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infectionEnterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling.Structure and inhibition of EV-D68, a virus that causes respiratory illness in children.Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interactionNovel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.Cell surface nucleolin facilitates enterovirus 71 binding and infection.Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey ModelCrystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
P2860
Q26771247-690F3873-2BA1-4CE4-B1C1-EE6242964D6FQ26775734-375FD43A-6A3A-4425-840B-588A4723A0C0Q26849627-9E2DEEEA-D8F6-4064-9972-D881996E5B65Q27010349-BADFC755-3697-4DCD-94BE-39D24F16ACCBQ27676881-F024D9F1-3471-4B1A-9255-D14A156A3201Q27677204-0EF57CF3-9AF8-434D-B42E-969752F89104Q27677960-238759A9-0C22-40AF-B49D-33BC9BDDEBE0Q27678469-15B22C39-DE82-4249-A80C-CFCA3B4EE6AEQ27679681-26D2F9B8-F166-4E46-9C49-A1E019E69E84Q27680869-915C352D-EC95-42AA-BBE0-5D542AB7DD53Q27680962-E173D6EF-5A39-4BDA-9AC3-CA42C0299D72Q27681480-179611B8-9294-44C1-A44B-1DF576442DCAQ27681644-3305CFCD-53AB-40DF-9659-D9F436F92C0DQ27682315-96B2367B-564B-4393-9F66-F79788F5C241Q27684518-A0D83F42-BBEF-4BC2-8F49-DB0DBCEA887FQ28485432-E91230A3-A6E5-40B0-94CA-DE29472640B3Q28541413-28663E0D-AB74-43E6-892C-84E78D0BCF99Q28543886-85C34EA2-4956-4DE3-9607-10550EABBAFBQ28550039-399704C9-4024-48BB-9205-91659B940E15Q28550496-974E304B-0D14-45F3-A4C8-57B8E289F725Q28606867-8CEBF27A-8B5C-4877-AF47-87188297A168Q30524112-6F409699-7666-42A7-843B-F5D0E8A5D52BQ33576597-6C3F675A-A4B9-43A6-A92A-293F6B813A21Q33685512-E8933AFF-D0CD-4BCC-93CC-6D906917C126Q33887710-33C01F92-559D-4815-9C7F-6D504F6EBAB6Q33914139-A4EB439A-A14C-4E96-B388-2E4BF330BFDEQ33945658-8E701299-3A9C-43F0-B99B-64481E506CBBQ34282430-8468D8ED-DB66-4310-B779-1D8F50B4821BQ34387141-5D8BBE95-B9D8-49B1-BB0D-4D8788897D03Q34435050-9C9FC043-5A5C-47AA-B7AF-70E04B11AC56Q34456331-333C1AA2-DC6F-4F77-815E-936BE9F189BAQ34603692-9EC9FFE6-A9A4-4EBD-A4A5-02428A30021CQ34607995-E16E8C4B-336D-467A-9164-1C25E2317B43Q34916727-9BF80FB3-70FF-4D3F-9E2A-9B0BFF8DD0C0Q34981056-09D6F9BE-5C88-4A3D-963D-5A62889619F9Q35055458-5BFA8608-EF19-408B-BD64-BD3549096821Q35641079-6C3E0E64-35B9-4D2A-9C15-3DE68F14A7EDQ35663722-67BC0AC4-BB37-4521-8362-E9B06179D2C0Q35693536-7EB1C82B-F45F-4D14-B61B-0723A72127E5Q35760496-96ED5D58-B393-4E05-A506-BD374908BD3B
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Crystal Structure of Human Enterovirus 71
@ast
Crystal Structure of Human Enterovirus 71
@en
Crystal Structure of Human Enterovirus 71
@nl
type
label
Crystal Structure of Human Enterovirus 71
@ast
Crystal Structure of Human Enterovirus 71
@en
Crystal Structure of Human Enterovirus 71
@nl
prefLabel
Crystal Structure of Human Enterovirus 71
@ast
Crystal Structure of Human Enterovirus 71
@en
Crystal Structure of Human Enterovirus 71
@nl
P2093
P2860
P3181
P356
P1433
P1476
Crystal Structure of Human Enterovirus 71
@en
P2093
Jane Cardosa
Pavel Plevka
Rushika Perera
P2860
P3181
P356
10.1126/SCIENCE.1218713
P407
P577
2012-06-08T00:00:00Z